1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Leucogen: new trials by email Literature Review of Leucogen trials Research Report on Leucogen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer Treat Regimen - Leucogen, Ribociclib | Phase 2 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 97 | 2026-01-07 | 2026-09-28 |
| A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC 5-fu, Lobaplatin, Placebo - Nasopharyngeal Carcinoma, Leucogen | Phase 3 | Not yet recruiting | Sun Yat-sen University | 132 | 2023-04-01 | 2023-03-22 |
Breast Neoplasms (1) · Leukopenia (1) · Nasopharyngeal Carcinoma (1) · Neutropenia (1)
Neoplasms (2) · Neoplasms by Site (2) · Agranulocytosis (1) · Breast Diseases (1) · Carcinoma (1) · Cytopenia (1) · Head and Neck Neoplasms (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukocyte Disorders (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1)
Fluorouracil (1) · Leyk (1) · lobaplatin (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Sun Yat-sen University (1)
China (2)